Si-Meng Zhao

Si-Meng Zhao

Auto-generated profile, based on publicly available information

Si-Meng Zhao

State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in Tetrahedron
Verified
Journal Article
Closed access
NLNa-Na Liu
Na-Na Liu
SZSi-Meng Zhao
Si-Meng Zhao
JZJing-Feng Zhao
Jing-Feng Zhao
GZGuang-Zhi Zeng
Guang-Zhi Zeng
NTNing-Hua Tan
Ning-Hua Tan
JLJian-Ping Liu
Jian-Ping Liu

16 November 2018 in Cancers
Verified
Journal Article
Open access
PDF file
XJXinyan Ji
Xinyan Ji
LSLihua Song
Lihua Song
LSLi Sheng
Li Sheng
AGAnhui Gao
Anhui Gao
YZYang Zhao
Yang Zhao
Bin ZhaoBin Zhao
Bin Zhao
The Hippo pathway restricts organ size during development and its inactivation plays a crucial role in cancer. Yes-associated protein (YAP) and its paralog transcriptional coactivator with PSD-95/Dlg/ZO-1 (PDZ)-binding motif (TAZ) are transcription co-activators and effectors of the Hippo pathway mediating aberrant enlargement of organs and tumor growth upon Hippo pathway inactivation. It has been demonstrated that genetic inactivation of YAP could be an effective approach to inhibit tumorigenesis. In order to identify pharmacological inhibitors of YAP, we screened a library of 52,683 compounds using a YAP-specific reporter assay. In this screen we identified cyclopeptide RA-V (deoxybouvardin) as a specific inhibitor of YAP and TAZ but not other reporters. Unexpectedly, later experiments demonstrated that RA-V represses the protein but not mRNA levels of YAP target genes. Nevertheless, RA-V strongly blocks liver enlargement induced by Mst1/2 knockout. Furthermore, RA-V not only inhibits liver tumorigenesis induced by YAP activation, but also induces regression of established tumors. We found that RA-V inhibits dedifferentiation and proliferation, while inducing apoptosis of hepatocytes. Furthermore, RA-V also induces apoptosis and inhibits proliferation of macrophages in the microenvironment, which are essential for YAP-induced tumorigenesis. RA-V is thus a drug candidate for cancers involving YAP/TAZ activation.

1 October 2015 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
HZHongmei Zhao
Hongmei Zhao
GZGuangzhi Zeng
Guangzhi Zeng
SZSimeng Zhao
Simeng Zhao
JXJunju Xu
Junju Xu
LKLingmei Kong
Lingmei Kong
SYShengchao Yang
Shengchao Yang

1 September 2012
Verified
Journal Article
Closed access
BKBin Kuang
Bin Kuang
JFJun-Ting Fan
Jun-Ting Fan
SZSi-Meng Zhao
Si-Meng Zhao
NTNing-Hua Tan
Ning-Hua Tan